Spanish registry for repeat pulsed-field ablation procedures for atrial fibrillation
Part of Heart & circulation clinical trials.
This trial is a registry that tracks patients who have had a second pulsed-field ablation (PFA) procedure for atrial fibrillation after a first PFA treatment. The goal is to learn more about how safe and effective these repeat procedures are.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation (a type of irregular heartbeat) and your doctor recommends a pulsed-field ablation procedure to treat it.
- You are willing to sign a consent form or have a legal representative do it.
- You are not currently taking part in another research study that would interfere with this one (but you can be in a purely observational registry or a required government registry).
- You are likely to live more than 12 months, in your doctor's opinion.
- You agree to come to the clinic for all required follow-up visits and tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This registry is collecting information to see how well the Farapulse PFA system works and how safe it is for treating atrial fibrillation (AF), a common heart rhythm problem. If you are scheduled to have an ablation for AF with this system, this study will follow your progress.
This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.
This study tracks people who have a procedure called pulsed field ablation to fix an abnormal heart rhythm (atrial arrhythmia). It's a registry, meaning researchers will collect information to learn more about how well the treatment works and how safe it is.
This registry study collects information from people with atrial fibrillation (an irregular heartbeat) who are having a procedure using the PulseSelect PFA system. It helps doctors understand how well this treatment works in real-world settings.
This trial tests a new device that uses pulsed-field energy to treat atrial fibrillation (a common heart rhythm problem) in people recently diagnosed. The goal is to restore a normal heartbeat.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.